US4356026A
(en)
*
|
1977-06-21 |
1982-10-26 |
Stauffer Chemical Company |
Substituted cyclopropylmethoxy phenyl ureas and their use as herbicides
|
US4230483A
(en)
*
|
1977-06-21 |
1980-10-28 |
Stauffer Chemical Company |
Substituted cyclopropylmethoxy phenyl carbamates and thiocarbamates and their use as herbicides
|
US4149874A
(en)
*
|
1977-06-21 |
1979-04-17 |
Stauffer Chemical Company |
Substituted cyclopropylmethoxy anilides and their use as herbicides
|
EP0002309B1
(en)
*
|
1977-10-12 |
1982-12-01 |
Imperial Chemical Industries Plc |
Acylanilides, process for their manufacture and pharmaceutical and veterinary compositions containing them
|
US4191775A
(en)
*
|
1977-12-15 |
1980-03-04 |
Imperial Chemical Industries Limited |
Amide derivatives
|
DK529378A
(da)
*
|
1978-01-09 |
1979-07-10 |
Shell Int Research |
Anilidderivater
|
ATE28864T1
(de)
*
|
1982-07-23 |
1987-08-15 |
Ici Plc |
Amide-derivate.
|
GB8617652D0
(en)
*
|
1986-07-18 |
1986-08-28 |
Ici Plc |
Acylanilide derivatives
|
US4921941A
(en)
*
|
1987-07-01 |
1990-05-01 |
Schering Corporation |
Orally active antiandrogens
|
US4895715A
(en)
*
|
1988-04-14 |
1990-01-23 |
Schering Corporation |
Method of treating gynecomastia
|
WO1998022432A1
(fr)
*
|
1996-11-18 |
1998-05-28 |
Yamanouchi Pharmaceutical Co., Ltd. |
Derives d'acylanilide a substitution acylamino ou composition comprenant ces derives
|
US6995284B2
(en)
*
|
2000-08-24 |
2006-02-07 |
The University Of Tennessee Research Foundation |
Synthesis of selective androgen receptor modulators
|
US7518013B2
(en)
*
|
2000-08-24 |
2009-04-14 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators
|
US7759520B2
(en)
*
|
1996-11-27 |
2010-07-20 |
University Of Tennessee Research Foundation |
Synthesis of selective androgen receptor modulators
|
US6071957A
(en)
*
|
1996-11-27 |
2000-06-06 |
The University Of Tennessee Research Corporation |
Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer
|
US20050038110A1
(en)
*
|
2000-08-24 |
2005-02-17 |
Steiner Mitchell S. |
Selective androgen receptor modulators and methods of use thereof
|
WO1998053826A1
(en)
*
|
1997-05-30 |
1998-12-03 |
The University Of Tennessee Research Corporation |
Non-steroidal agonist compounds and their use in male hormone therapy
|
US6019957A
(en)
*
|
1997-06-04 |
2000-02-01 |
The University Of Tennessee Research Corporation |
Non-steroidal radiolabeled agonist/antagonist compounds and their use in prostate cancer imaging
|
US20040176470A1
(en)
*
|
1998-05-07 |
2004-09-09 |
Steiner Mitchell S. |
Method for treatment and chemoprevention of prostate cancer
|
US8445534B2
(en)
|
2000-08-24 |
2013-05-21 |
University Of Tennessee Research Foundation |
Treating androgen decline in aging male (ADAM)-associated conditions with SARMs
|
US20070173546A1
(en)
*
|
2000-08-24 |
2007-07-26 |
Dalton James T |
Selective androgen receptor modulators and method of use thereof
|
IL154425A0
(en)
|
2000-08-24 |
2003-09-17 |
Univ Tennessee Res H Corp |
Selective androgen receptor modulators and methods of use thereof
|
US6838484B2
(en)
*
|
2000-08-24 |
2005-01-04 |
University Of Tennessee Research Foundation |
Formulations comprising selective androgen receptor modulators
|
AU8523001A
(en)
|
2000-08-24 |
2002-03-04 |
Gtx Inc |
Selective androgen receptor modulators and methods of use thereof
|
US8008348B2
(en)
*
|
2001-12-06 |
2011-08-30 |
University Of Tennessee Research Foundation |
Treating muscle wasting with selective androgen receptor modulators
|
US7855229B2
(en)
*
|
2000-08-24 |
2010-12-21 |
University Of Tennessee Research Foundation |
Treating wasting disorders with selective androgen receptor modulators
|
US6998500B2
(en)
*
|
2000-08-24 |
2006-02-14 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators and methods of use thereof
|
US7919647B2
(en)
*
|
2000-08-24 |
2011-04-05 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators and methods of use thereof
|
US7645898B2
(en)
*
|
2000-08-24 |
2010-01-12 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators and method of use thereof
|
US20040260108A1
(en)
*
|
2001-06-25 |
2004-12-23 |
Dalton James T. |
Metabolites of selective androgen receptor modulators and methods of use thereof
|
US7026500B2
(en)
*
|
2000-08-24 |
2006-04-11 |
University Of Tennessee Research Foundation |
Halogenated selective androgen receptor modulators and methods of use thereof
|
US7622503B2
(en)
*
|
2000-08-24 |
2009-11-24 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators and methods of use thereof
|
US7102026B2
(en)
*
|
2001-06-13 |
2006-09-05 |
Teva Gyógyszergyár Zártkörüen Müködö Részvénytársaság |
Process for preparing and isolating rac-bicalutamide and its intermediates
|
US20060287282A1
(en)
*
|
2001-06-25 |
2006-12-21 |
Steiner Mitchell S |
Compositions comprising a SARM ad GnRH agonist or a GnRH antagonist, and methods of use thereof
|
US7015253B2
(en)
*
|
2001-07-10 |
2006-03-21 |
American Medical Systems, Inc. |
Regimen for treating prostate tissue and surgical kit for use in the regimen
|
US20070161608A1
(en)
*
|
2001-12-06 |
2007-07-12 |
Dalton James T |
Selective androgen receptor modulators for treating muscle wasting
|
US8853266B2
(en)
*
|
2001-12-06 |
2014-10-07 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators for treating diabetes
|
BR0215115A
(pt)
*
|
2001-12-06 |
2005-04-19 |
Gtx Inc |
Tratamento de perda muscular com moduladores de receptores de androgênio seletivos
|
BRPI0307699A2
(pt)
*
|
2002-02-07 |
2015-06-16 |
Gtx Inc |
Tratamento de hiperplasia benigna da próstata com sarms.
|
US7344700B2
(en)
*
|
2002-02-28 |
2008-03-18 |
University Of Tennessee Research Corporation |
Radiolabeled selective androgen receptor modulators and their use in prostate cancer imaging and therapy
|
KR101088352B1
(ko)
*
|
2002-02-28 |
2011-11-30 |
유니버시티 오브 테네시 리서치 파운데이션 |
다치환된 선택적 안드로겐 수용체 조절자 및 이를 사용하는 방법
|
CA2476657A1
(en)
*
|
2002-02-28 |
2003-09-12 |
The University Of Tennessee Research Corporation |
Haloacetamide and azide substituted compounds and methods of use thereof
|
US7772433B2
(en)
*
|
2002-02-28 |
2010-08-10 |
University Of Tennessee Research Foundation |
SARMS and method of use thereof
|
US7803970B2
(en)
*
|
2002-02-28 |
2010-09-28 |
University Of Tennessee Research Foundation |
Multi-substitued selective androgen receptor modulators and methods of use thereof
|
US7741371B2
(en)
*
|
2002-06-17 |
2010-06-22 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators and methods of use thereof
|
US7022870B2
(en)
*
|
2002-06-17 |
2006-04-04 |
University Of Tennessee Research Foundation |
N-bridged selective androgen receptor modulators and methods of use thereof
|
SI1557411T1
(pt)
*
|
2002-07-12 |
2013-01-31 |
Astellas Pharma Inc |
|
CA2501797A1
(en)
*
|
2002-10-15 |
2004-04-29 |
Gtx, Inc. |
Treating obesity with selective androgen receptor modulators
|
US20040197928A1
(en)
*
|
2002-10-15 |
2004-10-07 |
Dalton James T. |
Method for detecting selective androgen receptor modulators
|
AU2003287077B2
(en)
*
|
2002-10-15 |
2007-09-20 |
University Of Tennessee Research Foundation |
Methylene-bridged selective androgen receptor modulators and methods of use thereof
|
CN1726020A
(zh)
*
|
2002-10-16 |
2006-01-25 |
Gtx公司 |
用sarm治疗老年男性雄激素缺乏(adam)相关的疾病
|
US20060276539A1
(en)
*
|
2002-10-16 |
2006-12-07 |
Dalton James T |
Treating Androgen Decline in Aging Male (ADAM)- associated conditions with SARMS
|
US20040087810A1
(en)
*
|
2002-10-23 |
2004-05-06 |
Dalton James T. |
Irreversible selective androgen receptor modulators and methods of use thereof
|
US8309603B2
(en)
|
2004-06-07 |
2012-11-13 |
University Of Tennessee Research Foundation |
SARMs and method of use thereof
|
US20040167103A1
(en)
*
|
2003-02-24 |
2004-08-26 |
Dalton James T. |
Haloacetamide and azide substituted compounds and methods of use thereof
|
CN1805921A
(zh)
*
|
2003-12-16 |
2006-07-19 |
Gtx公司 |
选择性雄激素受体调节剂的前药及其使用方法
|
US9884038B2
(en)
|
2004-06-07 |
2018-02-06 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulator and methods of use thereof
|
US9889110B2
(en)
|
2004-06-07 |
2018-02-13 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulator for treating hormone-related conditions
|
US20110237664A1
(en)
*
|
2004-06-07 |
2011-09-29 |
Dalton James T |
Selective androgen receptor modulators for treating diabetes
|
US20060258628A1
(en)
*
|
2004-07-20 |
2006-11-16 |
Steiner Mitchell S |
Compositions comprising 5-alpha reductase inhibitors, and SARMs and methods of use thereof
|
ES2581765T3
(es)
|
2006-08-24 |
2016-09-07 |
University Of Tennessee Research Foundation |
Acilanilidas sustituidas y métodos de uso de las mismas
|
US9844528B2
(en)
|
2006-08-24 |
2017-12-19 |
University Of Tennessee Research Foundation |
SARMs and method of use thereof
|
US9730908B2
(en)
|
2006-08-24 |
2017-08-15 |
University Of Tennessee Research Foundation |
SARMs and method of use thereof
|
US10010521B2
(en)
|
2006-08-24 |
2018-07-03 |
University Of Tennessee Research Foundation |
SARMs and method of use thereof
|
US9232959B2
(en)
|
2007-01-02 |
2016-01-12 |
Aquabeam, Llc |
Multi fluid tissue resection methods and devices
|
EP4238519A3
(en)
|
2007-01-02 |
2023-11-29 |
AquaBeam LLC |
Minimally invasive methods and devices for the treatment of prostate diseases
|
US20220096112A1
(en)
|
2007-01-02 |
2022-03-31 |
Aquabeam, Llc |
Tissue resection with pressure sensing
|
US20080245375A1
(en)
*
|
2007-04-05 |
2008-10-09 |
Medtronic Vascular, Inc. |
Benign Prostatic Hyperplasia Treatments
|
JP5456669B2
(ja)
*
|
2007-05-03 |
2014-04-02 |
エール ユニヴァーシティ |
局所活性「ソフト」抗アンドロゲン剤
|
US7968603B2
(en)
|
2007-09-11 |
2011-06-28 |
University Of Tennessee Research Foundation |
Solid forms of selective androgen receptor modulators
|
EP2259742B1
(en)
|
2008-03-06 |
2020-01-01 |
AquaBeam LLC |
Tissue ablation and cautery with optical energy carried in fluid stream
|
US9848904B2
(en)
|
2009-03-06 |
2017-12-26 |
Procept Biorobotics Corporation |
Tissue resection and treatment with shedding pulses
|
EP2907504B1
(en)
|
2011-02-08 |
2017-06-28 |
Halozyme, Inc. |
Composition and lipid formulation of a hyaluronan-degrading enzyme and the use thereof for treatment of benign prostatic hyperplasia
|
BR112014021482B1
(pt)
|
2012-02-29 |
2021-12-21 |
Procept Biorobotics Corporation |
Aparelho de ressecção de próstata
|
US9744149B2
(en)
|
2012-07-13 |
2017-08-29 |
Gtx, Inc. |
Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
|
LT2872482T
(lt)
|
2012-07-13 |
2020-12-28 |
Oncternal Therapeutics, Inc. |
Krūties vėžių gydymo būdas selektyviu androgeno receptoriaus moduliatoriumi
|
US10258596B2
(en)
|
2012-07-13 |
2019-04-16 |
Gtx, Inc. |
Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
|
US10314807B2
(en)
|
2012-07-13 |
2019-06-11 |
Gtx, Inc. |
Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
|
US9622992B2
(en)
|
2012-07-13 |
2017-04-18 |
Gtx, Inc. |
Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
|
US10987334B2
(en)
|
2012-07-13 |
2021-04-27 |
University Of Tennessee Research Foundation |
Method of treating ER mutant expressing breast cancers with selective androgen receptor modulators (SARMs)
|
US9969683B2
(en)
|
2012-07-13 |
2018-05-15 |
Gtx, Inc. |
Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS)
|
JP6403695B2
(ja)
|
2013-02-14 |
2018-10-10 |
プロセプト バイオロボティクス コーポレイション |
アクアアブレーションアクアビーム眼科手術方法および装置
|
BR112016005036A2
(pt)
|
2013-09-06 |
2020-04-07 |
Procept Biorobotics Corp |
aparelho para ressecção de tecido guiada por imagem automatizada
|
CN106572864B
(zh)
|
2014-06-30 |
2020-06-09 |
普罗赛普特生物机器人公司 |
流体射流组织切除和寒凝装置
|
CN107072591B
(zh)
|
2014-09-05 |
2021-10-26 |
普罗赛普特生物机器人公司 |
与靶器官图像的治疗映射结合的医师控制的组织切除
|